Atlas FDA

Predicate Research Report · generated 2026-08-22 · Print / save as PDF · Save to account

GSA · Predicate Candidate Screening

6 FDA 510(k) clearances under this product code; the 50 most recent screened below.

115 daysmedian FDA review time
281 days90th percentile
6clearances measured
K-numberDeviceApplicantDecidedReview daysRecalls (K-match)
K950073MYCOPLASMA PNEUMONIAE ANTIBODY LATEX AGGLUTINATION TEST SYSTShared Systems, Inc.1995-10-172810
K910833COLOR VUE TM- MYCOPLASMA PNEUMONIAESeradyn, Inc.1991-06-241170
K905493MERISTAR-MPMeridian Diagnostics, Inc.1991-01-30540
K903958SEROFASTIntl. Mycoplasma/Mdc Assoc.1990-12-211150
K883083MYCOPLASMA PNEUMONIAE ANTIBODY LATEX TEST SYSTEMMedical Diagnostic Technologies, Inc.1988-10-25960
K862630MYCOPLASMA PNEUMONIAE ANTIBODY LATEX TEST SYSTEMMedical Diagnostic Technologies, Inc.1986-09-03550

Methodology

Recall counts reflect FDA recall records explicitly referencing each K-number; FDA links recalls to K-numbers inconsistently, so 0 means "none found in FDA records," not "never recalled." Data: FDA openFDA, refreshed weekly. Verify decisions of consequence against the primary source. Full candidate set and CSV export: atlasbyauro.com.

Prepared with Atlas

Predicate research, review-time statistics and recall monitoring for 510(k) teams: atlasbyauro.com/fda